Skip to main content
Hemogenyx Pharmaceuticals Plc (LON:HEMO)
London flag London · Delayed Price · Currency is GBP · Price in GBX
697.00
+7.00 (1.01%)
Apr 29, 2026, 11:47 AM GMT

Hemogenyx Pharmaceuticals Cash Flow Statement

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-7.81-5.62-6.69-3.98-5.1-2.08
Upgrade
Depreciation & Amortization
0.630.640.650.20.130.11
Upgrade
Stock-Based Compensation
0.340.340.240.020.150.36
Upgrade
Other Operating Activities
-0.09-0.110.530.612.09-0.13
Upgrade
Change in Accounts Receivable
0.1-00-0-0.2-0.02
Upgrade
Change in Accounts Payable
0.720.350.03-0.030.3-0.04
Upgrade
Change in Other Net Operating Assets
0.540.26-0.870.27-0
Upgrade
Operating Cash Flow
-5.57-4.14-6.11-2.91-2.63-1.8
Upgrade
Capital Expenditures
-0.02-0.01-0.12-0.43-0.64-0.17
Upgrade
Sale (Purchase) of Intangibles
0.27----0.18-
Upgrade
Other Investing Activities
-0.010.010.090.01-0.120
Upgrade
Investing Cash Flow
0.24-0-0.03-0.42-0.94-0.17
Upgrade
Short-Term Debt Issued
-----0.46
Upgrade
Total Debt Issued
-----0.46
Upgrade
Long-Term Debt Repaid
--0.64-0.64-0.11-3.22-0.04
Upgrade
Net Debt Issued (Repaid)
-0.66-0.64-0.64-0.11-3.220.42
Upgrade
Issuance of Common Stock
2.843.935.25-123.18
Upgrade
Other Financing Activities
-0.27-0.21-0.17---0.39
Upgrade
Financing Cash Flow
1.913.084.45-0.118.783.21
Upgrade
Foreign Exchange Rate Adjustments
2.01-0.020.4-0.88-0.180.07
Upgrade
Miscellaneous Cash Flow Adjustments
---0.01--
Upgrade
Net Cash Flow
-1.42-1.09-1.29-4.315.031.31
Upgrade
Free Cash Flow
-5.59-4.15-6.22-3.34-3.26-1.97
Upgrade
Free Cash Flow Per Share
-1.58-1.26-2.20-1.36-1.69-1.90
Upgrade
Levered Free Cash Flow
-1.1-1.96-4.37-3.35-3.11-1.1
Upgrade
Unlevered Free Cash Flow
-0.95-1.79-4.18-3.35-2.24-1.08
Upgrade
Change in Working Capital
1.360.6-0.830.240.1-0.06
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.